Sparsentan Provides Better Proteinuria Reduction in FSGS ...Middle East

Medscape - News
Sparsentan Provides Better Proteinuria Reduction in FSGS
A post-hoc analysis of the DUPLEX trial shows significantly greater improvements in proteinuria-related outcomes vs irbesartan for tough-to-treat FSGS. Medscape Medical News

Read More Details
Finally We wish PressBee provided you with enough information of ( Sparsentan Provides Better Proteinuria Reduction in FSGS )

Apple Storegoogle play

Also on site :

Most viewed in News